Dr Tom Clutton-Brock named among world’s top 100 health technology innovators

26 July 2016

Dr Tom Clutton-Brock

Dr Tom Clutton-Brock

A leading Trust and University academic has been named one of the top 100 most influential drivers of the health technology revolution, globally.

Dr Tom Clutton-Brock, who works across the Queen Elizabeth Hospital Birmingham (QEHB) and the co-located University of Birmingham, is said to be among “the leaders who are transforming healthcare through technology”.

The accolade comes from Hot Topics, an online forum for leaders in technology which features stories, videos, audio and events, in association with Hotwire PR.

Dr Clutton-Brock, Reader in Anaesthesia and Intensive Care at the University and QEHB, is also Clinical Director of the Healthcare Technology Cooperative (HTC), a scheme run by the National Institute for Health Research (NIHR) to provide funding to NHS organisations to act as centres of expertise, developing new concepts which are applicable across the NHS.

Under the HTC banner, University Hospitals Birmingham NHS Foundation Trust, which runs the QEHB, works collaboratively with the University of Birmingham, Birmingham Children’s Hospital, the Royal Centre for Defence Medicine, plus patient groups, charities, and partners in industry.

The HTC addresses clinical areas of high morbidity and unmet need for NHS patients which have not benefited from a high degree of innovation. The focus is on healthcare technologies which aim to improve patient outcomes through reducing the effects of all forms of trauma, including reducing mortality, pain and long-term disability.

Dr Clutton-Brock said: “I’m pleased that the work we’re going here in Birmingham has been recognised by Hot Topics”.

“The Trust is a major UK centre of clinical excellence, with a world-leading academic partner in the University of Birmingham”.

“In particular, we’re working with our partners to develop new innovations which will ultimately benefit trauma patients”.

“New technology will play a pivotal role in improved survival and reduction in long- term disability.”

Dr Clutton-Brock qualified in medicine from Bristol University in 1980. He went on to gain an FRCP, FRCA and FFICM. He has carried out research for the University of Birmingham and is internationally recognised as an expert in medical devices.

Dr Clutton-Brock has been a Senior Clinical Academic in Anaesthesia and Intensive Care Medicine at the University of Birmingham since 1990.  He has maintained a career-long research interest in medical devices with particular interests in patient monitoring systems and point-of-care testing.

As well as having a clinical commitment at the QEHB, Dr Clutton-Brock is one of the Associate Medical Directors at UHB, Chair of NICE Interventional Procedures Advisory Committee.  He has also been one of the Senior Medical Officers (Devices Clinical) at the Medicines and Healthcare products Regulatory Agency (MHRA) and elected member of Council at the Royal College of Anaesthetists.

Until recently, he was interim Director of the Institute of Translational Medicine, a collaborative research facility delivered by Birmingham Health Partners and based in the original Queen Elizabeth Hospital Birmingham.